The United States health authorities have approved Pfizer’s COVID-19 booster shot for children as young as 12. They also reduced the time between the initial vaccination and the booster to 5 months from 6; the decision applies to all ages.
The decision of the Food and Drug Administration (FDA) comes as the pandemic flares up due to the Omicron variant. Schoolchildren are also expected to return by the millions to class after the holiday break.
The FDA said the approval comes after it relied on data from Israel where thousands of children aged 12 to 15 have received their booster dose. As of now, 4.1 million people 16 and older received a booster in Israel after five months and no safety concerns emerged.
They said that reducing the period to five months rather than six may provide better protection sooner for individuals against the highly transmissible Omicron variant.